Emergency Use Authorization of Covid Vaccines — Safety and Efficacy Follow-up Considerations | NEJM

Emergency Use Authorization of Covid Vaccines A median 2-month follow-up after completion of an investigational Covid-19 vaccine regimen is necessary to provide safety and effectiveness data tha

Sourced through Scoop.it from: www.nejm.org